The current status of the Biosecure Act is that it was passed ​ by the US House of Representatives on Sep 9, with a vote of ...

Artificial intelligence (AI) is now infiltrating core industries and according to Forbes, the market is expected to reach a ...

Months after divesting seven European sites, the Swedish contract development and manufacturing organisation (CDMO) Recipharm ...

The partners are preparing for commercialization of the lung cancer drug limertinib as they await an approval decision from China’s National Drug Administration.

Outsourcing Pharma sat down ahead of CPHI with Dr Andreas Raabe, CEO of Adragos Pharma, to explore the evolving world of ...

Patient recruitment is a critical and often challenging aspect of clinical trials, particularly for biopharmaceutical ...

Rebekah's father passed on his passion for science and problem solving to her and much her of childhood was spent doing fun ...

The proceeds of the financing will support the development of LoQus23’s lead candidate, a small molecule inhibitor that is ...

SK Group’s contract development and manufacturing organization (CDMO) arm SK pharmteco is spending $260 million to expand its ...